Related references
Note: Only part of the references are listed.FBXW7 Confers Radiation Survival by Targeting p53 for Degradation
Danrui Cui et al.
CELL REPORTS (2020)
Myeloid FBW7 deficiency disrupts redox homeostasis and aggravates dietary-induced insulin resistance
Cheng Wang et al.
REDOX BIOLOGY (2020)
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Radiation resistance of normal human astrocytes: the role of non-homologous end joining DNA repair activity
Michelle A. Bylicky et al.
JOURNAL OF RADIATION RESEARCH (2019)
The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response
Qiang Zhang et al.
NUCLEIC ACIDS RESEARCH (2019)
FBXW7 in Cancer: What Has Been Unraveled Thus Far?
Bethsebie Lalduhsaki Sailo et al.
CANCERS (2019)
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
Suhas V. Vasaikar et al.
NUCLEIC ACIDS RESEARCH (2018)
FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells
Jing Lin et al.
CANCER SCIENCE (2018)
Hepatic F-Box Protein FBXW7 Maintains Glucose Homeostasis Through Degradation of Fetuin-A
Jiejie Zhao et al.
DIABETES (2018)
Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism
Ryan J. Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Consumption of NADPH for 2-HG Synthesis Increases Pentose Phosphate Pathway Flux and Sensitizes Cells to Oxidative Stress
Susan J. Gelman et al.
CELL REPORTS (2018)
Wild-type and mutated IDH1/2 enzymes and therapy responses (vol 37, pg 1949, 2018)
Remco J. Molenaar et al.
ONCOGENE (2018)
Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Cells (vol 25, pg 1018, 2018)
Mehmet G. Badur et al.
CELL REPORTS (2018)
Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis
Daniel R. Wahl et al.
CANCER RESEARCH (2017)
2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity
Parker L. Sulkowski et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1
Stephane J. H. Ricoult et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
FBXW7 Facilitates Nonhomologous End-Joining via K63-Linked Polyubiquitylation of XRCC4
Qiang Zhang et al.
MOLECULAR CELL (2016)
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
Shunrong Ji et al.
CELL RESEARCH (2015)
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
Anna Stincone et al.
BIOLOGICAL REVIEWS (2015)
Tumor Suppression by the Fbw7 Ubiquitin Ligase: Mechanisms and Opportunities
Ryan J. Davis et al.
CANCER CELL (2014)
Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
Deliang Guo et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Tracing Compartmentalized NADPH Metabolism in the Cytosol and Mitochondria of Mammalian Cells
Caroline A. Lewis et al.
MOLECULAR CELL (2014)
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
Anh N. Tran et al.
NEURO-ONCOLOGY (2014)
Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth
Beatrice Griffiths et al.
CANCER & METABOLISM (2013)
Gliomagenesis Arising from Pten- and Ink4a/Arf-Deficient Neural Progenitor Cells Is Mediated by the p53-Fbxw7/Cdc4 Pathway, Which Controls c-Myc
Hong Sug Kim et al.
CANCER RESEARCH (2012)
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo et al.
NATURE (2012)
Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells
Fabian V. Filipp et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Inhibition of Ubiquitin Ligase F-box and WD Repeat Domain-containing 7α (Fbw7α) Causes Hepatosteatosis through Kruppel-like Factor 5 (KLF5)/Peroxisome Proliferator-activated Receptor γ2 (PPARγ2) Pathway but Not SREBP-1c Protein in Mice
Shin Kumadaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
Fonnet E. Bleeker et al.
ACTA NEUROPATHOLOGICA (2010)
The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Patrick S. Ward et al.
CANCER CELL (2010)
γH2AX foci analysis for monitoring DNA double-strand break repair Strengths, limitations and optimization
Markus Loebrich et al.
CELL CYCLE (2010)
A Phosphorylation Cascade Controls the Degradation of Active SREBP1
Maria T. Bengoechea-Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
DNA Repair by Homologous Recombination, But Not by Nonhomologous End Joining, Is Elevated in Breast Cancer Cells
Zhiyong Mao et al.
NEOPLASIA (2009)
FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients
Martin Hagedorn et al.
CELL DIVISION (2007)
Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCFFbw7
A Sundqvist et al.
CELL METABOLISM (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
IDH1 gene transcription is sterol regulated and activated by SREBP-1a and SREBP-2 in human hepatoma HepG2 cells: evidence that IDH1 may regulate lipogenesis in hepatic cells
I Shechter et al.
JOURNAL OF LIPID RESEARCH (2003)
Share Paper
